NO20071534L - Behandling av inflammatoriske forstyrrelser og smerte - Google Patents
Behandling av inflammatoriske forstyrrelser og smerteInfo
- Publication number
- NO20071534L NO20071534L NO20071534A NO20071534A NO20071534L NO 20071534 L NO20071534 L NO 20071534L NO 20071534 A NO20071534 A NO 20071534A NO 20071534 A NO20071534 A NO 20071534A NO 20071534 L NO20071534 L NO 20071534L
- Authority
- NO
- Norway
- Prior art keywords
- pain
- treatment
- inflammatory disorders
- mediated
- pro
- Prior art date
Links
- 206010065390 Inflammatory pain Diseases 0.000 title 1
- 208000027866 inflammatory disease Diseases 0.000 title 1
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 230000006052 T cell proliferation Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 230000000770 proinflammatory effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Quinoline Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0419828A GB0419828D0 (en) | 2004-09-07 | 2004-09-07 | The treatment of inflammatroy disorders and pain |
| GB0423926A GB0423926D0 (en) | 2004-10-27 | 2004-10-27 | The treatment of Inflammatory disorders and pain |
| PCT/GB2005/003452 WO2006027579A2 (fr) | 2004-09-07 | 2005-09-07 | Traitement de troubles et de douleurs inflammatoires |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20071534L true NO20071534L (no) | 2007-03-27 |
Family
ID=35757024
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20071534A NO20071534L (no) | 2004-09-07 | 2007-03-23 | Behandling av inflammatoriske forstyrrelser og smerte |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20080096971A1 (fr) |
| EP (1) | EP1786410A2 (fr) |
| JP (1) | JP2008512433A (fr) |
| KR (1) | KR20070083579A (fr) |
| AU (1) | AU2005281495A1 (fr) |
| BR (1) | BRPI0514931A (fr) |
| CA (1) | CA2579540A1 (fr) |
| IL (1) | IL181706A0 (fr) |
| MX (1) | MX2007002742A (fr) |
| NO (1) | NO20071534L (fr) |
| WO (1) | WO2006027579A2 (fr) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1754474A1 (fr) * | 2005-02-02 | 2007-02-21 | Eucro European Contract Research GmbH & Co. KG | Utilisation du S-Clenbutérol |
| MX2007012794A (es) * | 2005-04-13 | 2008-02-22 | Astion Pharma As | Composiciones para el tratamiento de trastornos del tejido conectivo de la piel. |
| GB0523964D0 (en) * | 2005-11-24 | 2006-01-04 | Arakis Ltd | The treatment of ophthalmic diseases |
| GB0604826D0 (en) * | 2006-03-09 | 2006-04-19 | Arakis Ltd | The treatment of inflammatory disorders and pain |
| GB0624757D0 (en) * | 2006-12-12 | 2007-01-17 | Sosei R & D Ltd | Novel compounds |
| CA2715110A1 (fr) | 2008-01-18 | 2009-09-17 | Centre National De La Recherche Scientifique (Cnrs) | Composes utilisables pour le traitement de douleurs neuropathiques |
| FR2926464B1 (fr) * | 2008-01-18 | 2012-01-20 | Centre Nat Rech Scient | Composes utilisables pour le traitement de douleurs neuropathiques |
| GB0805535D0 (en) | 2008-03-27 | 2008-04-30 | Univ Leicester | Scar prevention |
| WO2011126910A2 (fr) | 2010-03-30 | 2011-10-13 | Algynomics Inc. | Compositions et procédés pour le traitement de troubles somatosensoriels |
| US8716350B2 (en) | 2010-03-30 | 2014-05-06 | Algynomics Inc. | Compositions and methods for the treatment of somatosensory disorders |
| US8722636B2 (en) | 2011-01-31 | 2014-05-13 | New Market Pharmaceuticals, LLC | Animal treatments |
| AU2012379005B2 (en) | 2012-05-02 | 2017-12-21 | Newmarket Pharmaceuticals Llc | Pharmaceutical compositions for direct systemic introduction |
| GB2513297A (en) | 2013-03-08 | 2014-10-29 | Univ Leicester | Methods |
| US20160303133A1 (en) * | 2013-04-05 | 2016-10-20 | Numedii, Inc. | Treatment of gastrointestinal and other disorders |
| KR101567633B1 (ko) * | 2013-07-03 | 2015-11-10 | 바이오스펙트럼 주식회사 | 감귤 미성숙과 추출물, 또는 시네프린 또는 이의 염을 유효성분으로 포함하는 염증성 피부질환 치료 또는 예방용 조성물 |
| GB201714734D0 (en) * | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714740D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714736D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714745D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201903832D0 (en) | 2019-03-20 | 2019-05-01 | Atrogi Ab | New compounds and methods |
| GB201903827D0 (en) * | 2019-03-20 | 2019-05-01 | Atrogi Ab | New compounds and methods |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9905898D0 (en) * | 1999-03-15 | 1999-05-05 | Darwin Discovery Ltd | Controlled-dose formulation |
-
2005
- 2005-09-07 JP JP2007530760A patent/JP2008512433A/ja not_active Withdrawn
- 2005-09-07 US US11/662,115 patent/US20080096971A1/en not_active Abandoned
- 2005-09-07 EP EP05778391A patent/EP1786410A2/fr not_active Withdrawn
- 2005-09-07 CA CA002579540A patent/CA2579540A1/fr not_active Abandoned
- 2005-09-07 WO PCT/GB2005/003452 patent/WO2006027579A2/fr not_active Ceased
- 2005-09-07 AU AU2005281495A patent/AU2005281495A1/en not_active Abandoned
- 2005-09-07 MX MX2007002742A patent/MX2007002742A/es not_active Application Discontinuation
- 2005-09-07 KR KR1020077006370A patent/KR20070083579A/ko not_active Withdrawn
- 2005-09-07 BR BRPI0514931-2A patent/BRPI0514931A/pt not_active IP Right Cessation
-
2007
- 2007-03-05 IL IL181706A patent/IL181706A0/en unknown
- 2007-03-23 NO NO20071534A patent/NO20071534L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1786410A2 (fr) | 2007-05-23 |
| MX2007002742A (es) | 2007-05-23 |
| US20080096971A1 (en) | 2008-04-24 |
| AU2005281495A1 (en) | 2006-03-16 |
| KR20070083579A (ko) | 2007-08-24 |
| WO2006027579A2 (fr) | 2006-03-16 |
| CA2579540A1 (fr) | 2006-03-16 |
| IL181706A0 (en) | 2007-07-04 |
| JP2008512433A (ja) | 2008-04-24 |
| WO2006027579A3 (fr) | 2007-03-08 |
| BRPI0514931A (pt) | 2008-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20071534L (no) | Behandling av inflammatoriske forstyrrelser og smerte | |
| GB0402137D0 (en) | Novel compounds | |
| GB0402143D0 (en) | Novel compounds | |
| NO20081349L (no) | Pyrrolopyrimidinderivater som Syk-inhibitorer | |
| TW200714590A (en) | Heterocyclic inhibitors of MEK and methods of use thereof | |
| ATE439837T1 (de) | 5-gliedrige heterocyclische p-38 inhibitoren | |
| CY1116754T1 (el) | Παραγωγα νιτροκατεχολης ως αναστολεις της comt | |
| NO20082594L (no) | Pyrimidinylbenzotiofenforbindelser | |
| DE60315146D1 (de) | Heteroarylsubstituierte biphenylderivate als inhibitoren von p38-kinase | |
| TW200745004A (en) | Novel compounds, their preparation and use | |
| NO20062357L (no) | Indolinderivater og anvendelse av dem ved behandling av sykdomstilstander som cancer | |
| EA201070422A1 (ru) | Производные оксадиазола | |
| NO20074943L (no) | Roflumilast for behandlingen av diabetes mellitus | |
| WO2010038086A8 (fr) | Nouveaux composés | |
| IS2520B (is) | Nikótínamíð afleiður nytsamlegar sem P38 hindrar | |
| NO20075273L (no) | Nye forbindelser | |
| NO20073574L (no) | Triazolsubstituerte aminobenzofenonforbindelser | |
| EA201070423A1 (ru) | Диарильные соединения оксадиазолов | |
| NO20082096L (no) | Azaindol-2-karboksamidderivativer | |
| GB0402138D0 (en) | Novel compounds | |
| SE0203304D0 (sv) | Novel Coumpounds | |
| MX2008001428A (es) | Compuestos de imidazolil-pirimidina para uso en el tratamiento de trastornos proliferativos. | |
| WO2004037776A3 (fr) | Nouveaux composes, leur preparation et leur utilisation | |
| ATE515494T1 (de) | Neue verbindungen, deren herstellung und verwendung | |
| NO20083871L (no) | Bruken av bupropion metabolitter i behandlingen av betennelseslidelser |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |